Huge Blow to Anticoagulation Strategy Against Afib-Related Cognition Problems
Meeting Coverage > > AHA-- Microemboli now questioned as motorist of cognitive disability in atrial fibrillation
by Nicole Lou, Senior Staff Writer, MedPage Today November 17, 2024
CHICAGO-- Researchers stopped working to avoid cognitive disability in individuals with existing atrial fibrillation (Afib) by going the path of anticoagulation to alleviate subclinical brain infarcts, according to the BRAIN-AF trial.
Stopped early for futility, BRAIN-AF recommended a comparable danger of cognitive decrease, stroke, or short-term ischemic attack (TIA) whether Afib clients with a low danger of stroke-- a group without an existing indicator for antico...